Previous reports have shown that VPA synergistically interacts with chemotherapy or radiotherapy to enhance cytotoxicity in GBM cells by promoting HDAC-dependent transcriptional repression and histone hyperacetylation in vitro and in vivo, which improves survival in GBM patients [12, 56–62]. The gene discussed is HDAC9; the disease is glioblastoma.